DK116658B - Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5>-østrener. - Google Patents

Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5>-østrener.

Info

Publication number
DK116658B
DK116658B DK572664AA DK572664A DK116658B DK 116658 B DK116658 B DK 116658B DK 572664A A DK572664A A DK 572664AA DK 572664 A DK572664 A DK 572664A DK 116658 B DK116658 B DK 116658B
Authority
DK
Denmark
Prior art keywords
estrenes
methyl
preparation
therapeutically active
therapeutically
Prior art date
Application number
DK572664AA
Other languages
English (en)
Inventor
Jongh H De
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of DK116658B publication Critical patent/DK116658B/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK572664AA 1963-11-20 1964-11-20 Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5>-østrener. DK116658B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL300774 1963-11-20

Publications (1)

Publication Number Publication Date
DK116658B true DK116658B (da) 1970-02-02

Family

ID=19755228

Family Applications (1)

Application Number Title Priority Date Filing Date
DK572664AA DK116658B (da) 1963-11-20 1964-11-20 Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5>-østrener.

Country Status (6)

Country Link
US (1) US3383393A (da)
BR (1) BR6464588D0 (da)
CH (1) CH479570A (da)
DE (1) DE1468423A1 (da)
DK (1) DK116658B (da)
GB (2) GB1089915A (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3476783A (en) * 1965-10-08 1969-11-04 Smithkline Corp 6,6-ethylene-9alpha-fluoro steroids
US3673225A (en) * 1970-01-16 1972-06-27 Organon New 7-alkyl-steroids
US4038297A (en) * 1973-05-17 1977-07-26 Emery Industries, Inc. High molecular weight monocarboxylic acids and ozonization process for their preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3262949A (en) * 1956-11-13 1966-07-26 Syntex Corp 7-methyl androstane compounds
US3312720A (en) * 1961-03-29 1967-04-04 Organon 3-desoxy-19-nor-androstenes

Also Published As

Publication number Publication date
GB1089916A (en) 1967-11-08
DE1468423A1 (de) 1969-01-09
US3383393A (en) 1968-05-14
BR6464588D0 (pt) 1973-08-02
GB1089915A (en) 1967-11-08
CH479570A (de) 1969-10-15

Similar Documents

Publication Publication Date Title
DK128353B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive bis-chromoner.
DK116205B (da) Analogifremgangsmåde til fremstilling af 17α-alkanoyloxy-9α-halogen-16β-methyl-11β,21-dihydroxy-Δ&lt;1,4&gt;-pregnadien-3,20-dioner.
DK108500C (da) Fremgangsmåde til fremstilling af 1-glykosyl-5-azacytosiner.
DK111956B (da) Fremgangsmåde til fremstilling af 3,5-dioxo-17β-hydroxy-4,5-seco-Δ&lt;9&gt;-estren.
DK111113B (da) Fremgangsmåde til fremstilling af 3-methylflavon-8-carboxylsyre.
DK115400B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 3-keto-19-alkyl-androstaner.
DK112736B (da) Fremgangsmåde til fremstilling af N-(3-aminopyrazinoyl)-benzamidiner.
DK111889B (da) Fremgangsmåde til fremstilling af 3-N-substituerede tricycloundecaner.
DK121708B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 22-aza-cholestanderivater.
DK117635B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 3-(piperazinoalkyl)-pyrazoler.
DK120596B (da) Fremgangsmåde til fremstilling af acetoxymethylbenzylpenicillinat.
DK118825B (da) Fremgangsmåde til fremstilling af adrenocorticotropt virksomme tricosa- eller tetracosapeptider.
DK119107B (da) Fremgangsmåde til fremstilling af 11β-hydroperoxy-3-oxo-13-alkyl-Δ&lt;4,9&gt;-gonadiener.
DK117632B (da) Fremgangsmåde til fremstilling af 3-alkyliden-Δ&lt;4&gt;-estrener.
DK104461C (da) Fremgangsmåde til fremstilling af 3-amino-isoxazoler.
DK116658B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ&lt;5&gt;-østrener.
DK107031C (da) Fremgangsmåde til fremstilling af 2-halogenmethyl-quinazolin-3-oxider.
DK112235B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 21-dicyclohexylmethylcarbonater af 21-hydroxy-Δ&lt;4&gt;-pregnen-17α-ol-3,20-dioner.
DK104571C (da) Fremgangsmåde til fremstilling af trans-2-phenyl-3-methylmorpholin.
DK115327B (da) Fremgangsmåde til fremstilling af hydroxyphenylalkylphosphonater.
DK117488C (da) Fremgangsmåde til fremstilling af terapeutisk aktive 2α-3α-epithio-5α-androstaner.
DK121510B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ&lt;5(10)&gt;-østrener.
DK113991B (da) Fremgangsmåde til fremstilling af 2-chlor-3-oxo-butanamider.
FI43994C (fi) Menetelmä uusien terapeuttisesti vaikuttavien 1,2-diaryyli-4-alkyyli-3,5-diokso-pyratsolidiinien valmistamiseksi
DK108499C (da) Fremgangsmåde til fremstilling af 1-alkyl- eller 1-hydroxyalkyl-5-nitro-imidazol-2-carboxamider.